Raina obtained her M.Sc. in Chemistry from the University of Leipzig in 2012. Under the supervision of Prof. Christoph Schneider, her thesis project was focused on the synthesis of tetrahydrofurans via vinologous Mukaiyama-aldol-domino reaction. Afterwards, undertook an internship at Merck KGaA in Darmstadt, Germany.
For her PhD studies she moved to the Julius-Maximilians University of Wuerzburg. Under the supervision of Prof. Gerhard Bringmann, she worked on natural product synthesis and medicinal chemistry establishing total synthesis of antitumoral and antiinfective naphthylisoquinoline alkaloids and contributing the elucidation of the mode of action using labeled compounds. After her PhD, she spend some months in the groups of Prof. Martin Eilers and Dr. Elmar Wolf at the University of Wuerzburg for the synthesis of small bivalent molecules for the investigation on the therapeutic potential of the transcription factor Myc.
After obtaining her PhD from the University of Wuerzburg, she joined Prof. Paul Brennan Group at the Target Discovery Institute in May 2018, where she is working on the discovery of inhibitors as novel epigenetic chemical probes.